T6	Effect 0 39	Abdominal wall ulceration and mucinosis
T7	Treatment 53 89	recombinant human interferon-beta-1b
T8	Drug 53 89	recombinant human interferon-beta-1b
T5	Adverse_event 40 49	secondary
E1	Adverse_event:T5